Citation: | YI Jiahong, GUO Yarong, WANG Shumin, SONG Bin, QIU Haile, JIA Junmei. Effect of Down-regulation of HOXB7 Expression on Proliferation, Migration and Invasion Abilities of Hepatoma Cells[J]. Cancer Research on Prevention and Treatment, 2019, 46(11): 977-981. DOI: 10.3971/j.issn.1000-8578.2019.19.0674 |
To investigate the influence and partial underlying mechanism of HOXB7 on the proliferation, migration and invasion abilities of hepatoma cells.
SMMC-7721 and HepG2 cell lines with high expression of HOXB7 mRNA were detected by real-time fluorescence quantitative PCR. To assess the silence efficiency of shRNA, the expression of HOXB7 at mRNA and protein levels were detected by real-time PCR and Western blot in the hepatoma cells transfected with shRNA. The cell proliferation, invasion and migration abilities of hepatoma cells were measured by CCK8 assay, Transwell assay and cell scratch test. The expression of Smad3 and p-Smad3 in SMMC-7721 cells were measured by Western blot.
The expression of HOXB7 at mRNA and protein levels were reduced significantly after shRNA transfection, and the proliferation, invasion and migration abilities of SMMC-7721 cells were reduced at the same time. And the expression of p-Smad3 protein in TGF-β pathway was decreased.
HOXB7 could enhance the proliferation, invasion and migration abilities of hepatoma cells, which may be related to promoting the phosphorylation of Smad3 in TGF-β pathway.
[1] |
European Association for the Study of the Liver. EASL clinical practice guidelines: Management of hepatocellular carcinoma[J]. J Hepatol, 2018, 69(1): 182-236. http://d.old.wanfangdata.com.cn/Periodical/wcbxhgbxzz201806001
|
[2] |
Dalton-Fitzgerald E, Tiro J, Kandunoori P, et al. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2015, 13(4): 791-798. el. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=388147547641b9a572f21bd1f1e466eb
|
[3] |
Platais C, Hakami F, Darda L, et al. The role of HOX genes in head and neck squamous cell carcinoma[J]. J Oral Pathol Med, 2016, 45(4): 239-247. http://cn.bing.com/academic/profile?id=a5da42db611a9c961b4a4334fa6a9301&encoded=0&v=paper_preview&mkt=zh-cn
|
[4] |
张伟丽, 陈超. HOXB7基因沉默对人胃癌细胞活力、迁移和侵袭的影响[J].中国病理生理杂志, 2016, 32(10): 1824-1829. http://d.old.wanfangdata.com.cn/Periodical/zgblslzz201610016
Zhang WL, Chen C. Effects of transcription factor HOXB7 silencing on viability, invasion and migration of SGC-7901 cells[J]. Zhongguo Bing Li Sheng Li Za Zhi, 2016, 32(10): 1824-1829. http://d.old.wanfangdata.com.cn/Periodical/zgblslzz201610016
|
[5] |
李劲松, 韩亮, 于洋, 等. HOXB7对非小细胞肺癌A549细胞增殖的影响[J].肿瘤防治研究, 2015, 42(11): 1119-1123. doi: 10.3971/j.issn.1000-8578.2015.11.013
Li JS, Han L, Yu Y, et al. HOXB7 regulates proliferation of non-small cell lung cancer cell A549[J]. Zhong Liu Fang Zhi Yan Jiu, 2015, 42(11): 1119-1123. doi: 10.3971/j.issn.1000-8578.2015.11.013
|
[6] |
Zhang R, Leng H, Huang J, et al. miR-337 regulates the proliferation and invasion in pancreatic ductal adenocarcinoma by targeting HOXB7[J]. Diagn Pathol, 2014, 9: 171. http://cn.bing.com/academic/profile?id=a1a3028d2b41179395adf82266ce252c&encoded=0&v=paper_preview&mkt=zh-cn
|
[7] |
Tsuboi M, Taniuchi K, Shimizu T, et al. The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells[J]. J Biol Chem, 2017, 292(43): 17681-17702. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=0a82ec5867be77a6155c9d58ec32d608
|
[8] |
Liu S, Jin K, Hui Y, et al. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway[J]. Cancer Res, 2015, 75(4): 709-719. http://cn.bing.com/academic/profile?id=c0b9cd8151e87827e2b436d562a047dc&encoded=0&v=paper_preview&mkt=zh-cn
|
[9] |
Huan HB, Yang DP, Wen XD, et al. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition[J]. J Exp Clin Cancer Res, 2017, 36(1): 86. http://cn.bing.com/academic/profile?id=375fbbc999b4d478ae64acb4ef20f37b&encoded=0&v=paper_preview&mkt=zh-cn
|
[10] |
Dooley S, ten Dijke P. TGF-beta in progression of liver disease[J]. Cell Tissue Res, 2012, 347(1): 245-256. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_db1329c72ce1263767469944865bdd9e
|
[11] |
Han G, Li F, Singh TP, et al. The pro-inflammatory role of TGFbeta1: a paradox?[J]. Int J Biol Sci, 2012, 8(2): 228-235. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_7737a48ac0e6b4dc6a061f6c458fb4a1
|
[12] |
Masamune A, Yoshida N, Hamada S, et al. Exosomes derived from pancreatic cancer cells induce activation and profibrogenic activities in pancreatic stellate cells[J]. Biochem Biophys Res Commun, 2018, 495(1): 71-77. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=c95f1b27e46756203697ecd9418de34c
|
[13] |
Komatsu H, Iguchi T, Masuda T, et al. HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma[J]. Anticancer Res, 2016, 36(6): 2767-2773. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=67160501b92101e801fa335b976fb4e8
|
[14] |
Chen W, Zheng R, Baade PD, et al. Cancer staistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. http://cn.bing.com/academic/profile?id=57bdbfab0c5599c2d2880023763491e2&encoded=0&v=paper_preview&mkt=zh-cn
|
[15] |
彭洁琼, 刘波, 韩大力.精准医疗背景下肝细胞肝癌内科治疗研究进展[J].精准医学杂志, 2018, 33(3): 197-199. http://d.old.wanfangdata.com.cn/Periodical/jzyxzz201803003
Peng JQ, Liu B, Han DL. Research progress in the medical therapy of hepatocellular carcinoma under the background of precision medical treatment[J]. Jing Zhun Yi Xue Za Zhi, 2018, 33(3): 197-199. http://d.old.wanfangdata.com.cn/Periodical/jzyxzz201803003
|
[16] |
杨洋, 郭磊, 郭卫星.数字医学三维成像技术在原发性肝癌治疗中的应用[J].中华肝脏外科手术学电子杂志, 2019, 8(1): 14-17. http://d.old.wanfangdata.com.cn/Periodical/zhgzwkssxdzzz201901004
Yang Y, Guo L, Guo WX. Application of digital medical 3D imaging in treatment of primary liver cancer[J]. Zhonghua Gan Zang Wai Ke Shou Shu Xue Dian Zi Za Zhi, 2019, 8(1): 14-17. http://d.old.wanfangdata.com.cn/Periodical/zhgzwkssxdzzz201901004
|
[17] |
Gong XL, Qin SK. Progress in systemic therapy of advanced hepatocellular carcinoma[J]. World J Gastroenterol, 2016, 22(29): 6582-6594. http://cn.bing.com/academic/profile?id=b94ef14b6b5330511e344a8b0b6774f2&encoded=0&v=paper_preview&mkt=zh-cn
|
[18] |
Yuan W, Zhang X, Xu Y, et al. Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinom[J]. Mol Carcinog, 2014, 53(1): 49-57. https://www.ncbi.nlm.nih.gov/pubmed/22911672
|
[19] |
Jin K, Sukumar S. A pivotal role for HOXB7 protein in endocrine resistant breast cancer[J]. Oncoscience, 2015, 2(11): 917-919. http://cn.bing.com/academic/profile?id=b6d0f2cc3b6a48b5b9bb07c6f07dbf6b&encoded=0&v=paper_preview&mkt=zh-cn
|
[20] |
Wang M, Xu Y, Wang YH, et al. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma[J]. Oncotarget, 2017, 8(29): 47121-47135. http://cn.bing.com/academic/profile?id=b199c086256cf8c2b57aa5751f7cfcd4&encoded=0&v=paper_preview&mkt=zh-cn
|
[21] |
Yang Y, Chen J, Chen Q. Upregulation of HOXB7 promotes proliferation and metastasis of osteosarcoma cells[J]. Mol Med Rep, 2017, 16(3): 2773-2778. http://cn.bing.com/academic/profile?id=f3973e02da6ecdf9232cc23ef6681a3e&encoded=0&v=paper_preview&mkt=zh-cn
|
[22] |
Liao WT, Jiang D, Yuan J, et al. HOXB7 as a prognostic factor and mediator of colorectal cancer progression[J]. Clin Cancer Res, 2011, 17(11): 3569-3578. http://cn.bing.com/academic/profile?id=ea08465044e640908fd55ed91409b0b2&encoded=0&v=paper_preview&mkt=zh-cn
|
[23] |
Neuzillet C, Tijeras-Raballand A, Cohen R, et al. Targeting the TGFβ pathway for cancer therapy[J]. Pharmacol Thera, 2015, 147: 22-31. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_d5a77e29d2c382f1e2990a6270c19a0e
|
[24] |
倪卓然, 谢坤, 耿小平.上皮间质转化在肝细胞癌转移中作用的研究进展[J].肝胆外科杂志, 2015, 23(6): 469-472. http://d.old.wanfangdata.com.cn/Periodical/gdwkzz201506022
Ni ZR, Xie K, Geng XP. Research progress on role of epithelial-mesenchymal transformation in metastasis of hepatocellular carcinoma[J]. Gan Dan Wai Ke Za Zhi, 2015, 23(6): 469-472. http://d.old.wanfangdata.com.cn/Periodical/gdwkzz201506022
|
[25] |
陆珠凤, 黄锦龙, 甘伟, 等. Smad3蛋白在肝细胞癌中的作用[J].中华肝胆外科杂志, 2017, 23(6): 430-432. http://d.old.wanfangdata.com.cn/Periodical/zhgdwk201706020
Lu ZF, Huang JL, Gan W, et al. Research progress on Smad3 protein in hepatocellular carcinoma[J]. Zhonghua Gan Dan Wai Ke Za Zhi, 2017, 23(6): 430-432. http://d.old.wanfangdata.com.cn/Periodical/zhgdwk201706020
|
[1] | XIE Zhuanhong, XU Yunpeng, MA Huimin, WANG Xiang. Effects of Tspan8 Gene Knockout Combined with Anlotinib on Proliferation, Migration, Invasion and Apoptosis of Colon Cancer SW480 Cells[J]. Cancer Research on Prevention and Treatment, 2022, 49(10): 1028-1036. DOI: 10.3971/j.issn.1000-8578.2022.22.0198 |
[2] | WANG Kaiqiong, XING Yilei, QIAO Xin, LI Sizong, GONG Dongwei, YU Zhiwei, WU Yiqiang. Effects of miR-144 on Proliferation, Migration, Invasion and PI3K Pathway of Pancreatic Cancer SW1990 Cells[J]. Cancer Research on Prevention and Treatment, 2019, 46(10): 879-883. DOI: 10.3971/j.issn.1000-8578.2019.18.1524 |
[3] | YANG Jilan, LI Yang, DENG Mingjia, HU Fengdi, XIE Lin, LONG Tingfeng. Effects of MicroRNA-4465 on Apoptosis and Invasion of Colon Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2019, 46(9): 778-783. DOI: 10.3971/j.issn.1000-8578.2019.19.0050 |
[4] | ZHOU Xiaolei, ZHU Chongyue, ZHANG Shiguang, ZHOU Zhiyan, LI Haichao, ZOU Wei. NDRG2 Inhibits Migration of Breast Cancer Cells Through Upregulating PTEN Expression[J]. Cancer Research on Prevention and Treatment, 2017, 44(1): 5-10. DOI: 10.3971/j.issn.1000-8578.2017.01.002 |
[5] | LI Jinsong, HAN Liang, YU Yang, LIU Yong. HOXB7 Regulates Proliferation of Non-small Cell Lung Cancer Cell A549[J]. Cancer Research on Prevention and Treatment, 2015, 42(11): 1119-1123. DOI: 10.3971/j.issn.1000-8578.2015.11.013 |
[6] | MENG Liang, YU Xiaoxiang, LIU Zhiming, JI Baowei, CHEN Zhibiao, FAN Cheng, CHEN Bo. Role of Aquaporin-4 in Migration of Human Astrocytoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 756-759. DOI: 10.3971/j.issn.1000-8578.2015.08.002 |
[7] | ZHANG Rong, JIANG Tao, LONG Chihui, SUN Beibei, YAN Zhixiong, SHI Hairong. Effect of Down-regulated I2PP2A Expression on Proliferation and Migration of Gastric Carcinoma Cell Line BGC-823[J]. Cancer Research on Prevention and Treatment, 2015, 42(03): 233-237. DOI: 10.3971/j.issn.1000-8578.2015.03.005 |
[8] | Abidan•Tuerhanjiang, YANG Runfeng, WANG Tian, LI Sha, LI Yan, XIANG Tao. Construction of shRNA Eukaryotic Expression Vector Targeting Human Papillomavirus Type 16 E6/E7 Gene and Its Effects on Proliferation and Migration of SiHa Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 392-396. DOI: 10.3971/j.issn.1000-8578.2014.05.010 |
[9] | LIU Pei-gen, MA Li-lin, ZHU Jian-wei. Effect of Oxidative Stress Cell Migration,Vascular Epithelial Growth Factor Expression and Gap Junction Intercellular Communication on Colon Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(08): 857-860. DOI: 10.3971/j.issn.1000-8578.2011.08.002 |
[10] | DU Jun xiang, WANG Rong, WU Xiang hua, WAN Da fang, GU Jian ren. Effects on Sensitivity to Chemotherapy in the Raji Cell Transfected with Exogenous HCAP1 Gene[J]. Cancer Research on Prevention and Treatment, 2004, 31(06): 330-332. DOI: 10.3971/j.issn.1000-8578.895 |